Skip to content
Search

Latest Stories

RPS Wales announces next steps for pharmacy’s 2030 vision

RPS Wales announces next steps for pharmacy’s 2030 vision

The RPS Wales Conference celebrated the significant progress made in pharmacy in Wales

RPS Wales will once again spearhead the development of new three-year goals to help pharmacy in Wales advance toward its 2030 vision as outlined in Pharmacy: Delivering a Healthier Wales (PDaHW).

Elen Jones, Director of RPS Wales, and Jonathan Simms, Chair of the Welsh Pharmaceutical Committee, announced during the recent RPS Wales Conference.


Jones said: “I’d like to thank the Welsh Government and the Welsh Pharmaceutical Committee for once again entrusting RPS to take this work forward.”

This iteration of PDaHW builds on the original 10-year plan, published in 2019, and the two series of stepping stone goals established from 2019-2022 and 2022-2025.

Work on the new three-year goals will begin in early 2025.

“As always, we want to make sure the new goals reflect the views and ambitions of pharmacy teams in Wales. Therefore, we will be hosting a number of engagement events across Wales so that everyone has an opportunity to have their voice heard,” Jones said.

In addition to the announcement regarding the next steps for the 2030 vision, the RPS Wales Conference celebrated the significant progress made in pharmacy in Wales.

The conference featured presentations on the strategic developments undertaken by Digital Health and Care Wales, Health Education and Improvement Wales, the newly established NHS Wales Joint Commissioning Committee, and an overview of the Transforming Access to Medicines (TRAMS) programme undertaken by the NHS Wales Shared Wales Services Partnership.

Another highlight of the conference was eight quick-fire PDaHW Trailblazer talks from pharmacists and pharmacy technicians from all over Wales, which highlighted high-quality and innovative practices aligned with the PDaHW vision.

Nearly 200 members of pharmacy teams from all over Wales attended the RPS Wales Conference.

Launched in 2019, the 2030 vision for pharmacy in Wales sets long term ambitions for how patients will benefit from the expertise of pharmacy teams. It also includes a number of interim, three-year goals that act as stepping-stones toward the vision

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less